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Abstract
Purpose—Adiponectin is a promising biomarker linking obesity and disease risk; however,
limited data are available regarding adiponectin in black women among whom obesity is highly
prevalent.
Methods—A cross-sectional analysis was conducted to assess racial differences and correlates of
serum adiponectin measured in 996 black and 996 white women enrolled in the Southern
Community Cohort Study through Community Health Centers in twelve southeastern states from
2002–2006.
Results—Blacks had significantly lower adiponectin levels than whites (median 10.9 versus 14.9
ug/ml, Wilcoxon p<0.0001). Among blacks, adiponectin was lower among overweight and obese
women compared to healthy weight women but showed no clear decreasing trend with increasing
severity of obesity; adjusted geometric means (95% confidence interval) were 15.0 (13.8–16.4),
11.5 (10.6–12.5), 9.7 (9.0–10.6), 11.4 (10.3–12.6), and 10.9 (9.5–12.6) ug/ml for body mass index
[BMI] categories of 18.5–24.9, 25–29.9, 30–34.9, 35–39.9, and 40–45 (p for trend<0.0001). In
contrast, among whites there was a monotonic reduction in adiponectin over increasing BMI
(adjusted geometric means = 19.9 (18.3–21.7), 15.1 (13.9–16.4), 14.3 (13.2–15.5), 12.5 (11.2–
13.9), and 11.0 (9.7–12.5) ug/ml, p for trend<0.0001). BMI, age, HDL-cholesterol, and
hypertension were important correlates of adiponectin in both groups.
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Conclusions—Among women, racial differences exist in both the magnitude and form of the
adiponectin-BMI association.
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INTRODUCTION
Adiponectin is a protein produced exclusively in adipose tissue that appears to play a critical
role in mediating physiological effects such as insulin sensitivity, inflammatory response,
and cell proliferation. Adiponectin levels are inversely associated with obesity and are
thought to decrease in individuals with increased adiposity through down-regulation of
adiponectin receptors (1). Adiponectin may also be affected by diet, physical activity,
comorbidities, and other environmental factors as well as variation in genes encoding
adiponectin or its receptors (1). Because adiponectin is inversely associated with obesity
phenotypes as well as several obesity-related diseases (2), there is speculation that
adiponectin activity may be a useful target in the prevention of cardiovascular disease,
cancer, and type 2 diabetes (1,2). With the highest prevalence of obesity found among non-
Hispanic black women (39%) and the lowest among non-Hispanic white women (22%) (3),
differences in adiponectin levels across race groups may contribute to disparities in obesity-
related diseases between black and white women.
Identifying correlates of adiponectin and ascertaining whether they vary by race is likely to
enhance the development of effective adiponectin-related chemopreventive strategies. Thus,
the goal of this analysis was to examine associations between adiponectin levels, body mass
index (BMI), and other potential correlates and to assess whether associations varied by
race.
METHODS AND PROCEDURES
Institutional Review Boards at Vanderbilt University, Meharry Medical College, and the
University of North Carolina at Chapel Hill approved this study.
Study population
The Southern Community Cohort Study (SCCS) is a prospective epidemiologic cohort study
designed to examine racial disparities in cancer incidence and mortality (4). Study
enrollment began in 2002 in 12 southeastern states at Community Health Centers (CHC)
which are government-funded facilities providing health services primarily to low-income
individuals in medically underserved areas (5). Potential participants included anyone
entering the CHC such as patients, persons accompanying patients, and individuals utilizing
CHC pharmacy or dental services. Individuals were eligible if they had not been under
treatment for cancer in the past year. A personal or family history of cancer or elevated risk
factors for cancer was not used to determine eligibility. Additionally, as described
previously (4), participants were required to be age 40–79 years and English-speaking. From
over 47,000 SCCS participants enrolled through early 2006, a sub-sample of 2,000 women
who provided a blood sample at study enrollment and self-reported their race as either
`Black/African American' or `White' was selected for further biomarker analyses. This
included a random sample of 395 women selected in 2005 within three strata (race, BMI,
and smoking status) and a second random sample of 1,605 women selected in 2006 in equal
numbers across race, BMI, and menopausal status categories.
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Trained study interviewers led all participants through a structured questionnaire using a
computer-assisted interview with extensive skip patterns and range and logic checks. The
interview elicited information including demographics, anthropometrics, and several aspects
of health and behavior. Physical activity was measured using a questionnaire developed for
the SCCS to comprehensively assess active and sedentary behaviors at the time of the
interview. Dietary intake in the year prior to the baseline interview was measured using an
89-item food frequency questionnaire (FFQ) designed specifically for the SCCS to elicit
information about foods most commonly eaten in the southeastern United States (6,7). For
the 20% of women who were patients in the CHC on the day of the baseline interview,
measured height and weight were abstracted from medical records for validation purposes.
Participants self-reported diagnoses of medical conditions including diabetes, heart attack or
coronary bypass surgery, hypertension, high cholesterol, and depression by responding
“Yes” to questions beginning “Has a doctor ever told you that you have…?”
A convenience blood sample was collected at the time of recruitment using one EDTA-
containing plasma tube and one serum BD Vacutainer® tube. For this study, the median
time (hours) between the last reported meal and blood collection was 6.0 for blacks and 6.3
for whites (p=0.07). Fasting blood, defined as at least 8 hours since last meal, was collected
for 44% of the participants. Blood samples were shipped cold to Vanderbilt University in
Nashville, TN, where they were processed for storage at −80° C. 84% of the blood samples
were received the day after the blood draw and 98% were received within two days. The
samples were frozen for an average of 2.6 years (range 3 months to 5 years) prior to
analysis.
Laboratory assays
Adiponectin levels were measured in serum by immunoassay using the LINCOplex kit
(Luminex® xMAP™ Technology, St. Louis, MO) in the Vanderbilt Hormone Assay and
Analytical Services Core Laboratory in duplicate for each woman. The average of the two
measurements was used in all analyses. Duplicate sets of samples for five randomly selected
women as well as five repeat samples from each of two pooled samples were measured to
assess the reliability and validity of the assay. Adiponectin levels were successfully
measured in 1,992 of the 2,000 samples (eight samples failed due to a filter plate error or
low sample volume). The intra-assay coefficient of variation was 9.4%. High-density
lipoprotein (HDL) cholesterol was measured in serum by the Vanderbilt Lipid Laboratory
using the ACE Clinical Chemistry System and the ACE HDLC Reagent (#SA1038)
following the manufacturer's protocols (Alfa Wassermann, Inc, West Caldwell, NJ). The
intra-assay coefficient of variation was 1.6%. Neither adiponectin nor HDL-cholesterol
levels differed by fasting status (for adiponectin, p=0.3 for blacks, p=0.6 for whites; for
HDL, p=0.5 for blacks, p=0.4 for whites).
Statistical Methods
For this cross-sectional analysis, data from 1,992 women with measured adiponectin were
analyzed. BMI was calculated from self-reported values as [weight (kg)] / [height (m)2].
Dietary intakes, total physical activity, and HDL-cholesterol were categorized into quartiles
based on the distribution of the entire sample. Other characteristics were categorized as
shown in Table 1. The Wilcoxon signed rank test was used to compare adiponectin levels
between groups.
Adiponectin had a skewed distribution (Figure 1), and therefore was log-transformed to
better meet modeling assumptions (8). To ease presentation, back-transformed values are
shown. Linear regression models were constructed for blacks and whites separately. All
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models were adjusted for sample selection (395 selected in 2005 versus 1605 selected later)
and age at baseline interview. Further adjustment for factors used in the sample selection
(cigarette smoking status and menopausal status) did not alter the results and were not
included in the models presented here. Categorized covariates with inherent order were
modeled using indicator variables rather than as ordinal variables because the assumption of
linearity was not generally met.
The first analytic objective was to characterize the relationship between adiponectin and
BMI within each race group. BMI (continuous) was regressed on adiponectin, and potential
confounders (determined from the literature and categorized as shown in Table 1) were
added to the model using backwards model selection with a change-in-estimate criterion of
≥ 5%. Linear trend tests were conducted via F-tests of the continuous BMI variable.
Potential modifiers of the BMI-adiponectin relationship were assessed using the likelihood
ratio test (LRT) to compare models with and without interaction terms for BMI and potential
modifiers. Additionally, adjusted geometric means for adiponectin were calculated from
linear regression models that included standard categories of BMI (<18.5, 18.5–24.9, 25–
29.9, 30–34.9, 35–39.9, and 40–45 kg/m2) and the final set of confounders.
The second analytic goal was to determine correlates of adiponectin after adjustment for
BMI. BMI was forced into the linear regression model and potential correlates were then
added sequentially. Models were compared using Akaike's Information Criterion (AIC)
which balances model fit with model complexity (9), and potential correlates were included
in the final model as long as their addition resulted in an AIC value at least one unit lower
than the AIC for the smaller-order model.
SAS/STAT software, Version 9.1 of the SAS System for Windows (SAS Institute Inc.,
Cary, NC, USA) was used for all analyses.
RESULTS
Adiponectin levels were 25% lower among black women compared to white women
(medians: 10.9 versus 14.9 ug/ml, respectively, Wilcoxon p<0.0001). After adjustment for
BMI and age, adiponectin was still significantly lower in blacks (p<0.0001). Unadjusted
adiponectin levels decreased with increasing BMI categories in both groups although not as
consistently among blacks (Table 1). There was a strong positive association between
adiponectin and both age and HDL-cholesterol while adiponectin was slightly lower among
women reporting diabetes or hypertension. Unadjusted adiponectin levels increased with
increasing alcohol consumption in whites but not in blacks. Adiponectin was not
consistently associated with education, income, physical activity, cigarette smoking, or any
of the dietary or reproductive indices.
There was a strong linear association between continuous BMI and adiponectin in both race
groups (test for linear trend, p<0.0001 for black and white women). Figure 2 illustrates race-
specific associations between categories of BMI and adiponectin adjusted for HDL-
cholesterol, the only variable found to be a confounder of the BMI-adiponectin relationship.
Adjusted adiponectin means for blacks were lower than those for whites within each
category of BMI although the differences for women in the highest categories of BMI (35–
39.9 and 40+) were small. Among blacks, adiponectin decreased over BMI values up to 30–
34.9 before leveling off at the highest levels of BMI. In contrast, among whites, adiponectin
levels were lower with each increasing category of BMI. Menopausal status did not modify
the BMI-adiponectin relationship (LRT p=0.9 for blacks, p=0.6 for whites) (data not
shown). In models restricted to 421 black and 450 white women with fasting blood samples,
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the association between BMI and adiponectin was essentially unchanged for both groups
(data not shown).
Table 2 shows race-specific prediction models for adiponectin. Based on the AIC values,
BMI was an important correlate of adiponectin in both race groups although the regression
coefficient was larger in magnitude among whites. Age, HDL-cholesterol, and hypertension
were also significant correlates of adiponectin in both groups based on the AIC
comparisons. None of the other factors examined added additional predictive value to the
models.
As both diabetes and treatment for diabetes have been shown to affect adiponectin levels
(10), we repeated our main analyses in the subset of non-diabetic women in this study
(N=776 black and N=832 white). Among the non-diabetics, median adiponectin levels
remained significantly lower in blacks compared to whites (median: 11.0 versus 15.3 ug/ml,
respectively, Wilcoxon p<0.0001). Adjusted geometric means for adiponectin across
categories of BMI were also not appreciably different in either race group among the non-
diabetic women compared to the patterns observed in the entire sample (for BMI categories
of 18.5–24.9, 25–29.9, 30–34.9, 35–39.9, and 40–45, adjusted adiponectin means were 15.3,
11.4, 9.7, 11.2, and 9.9 in non-diabetic black women and 20.1, 15.4, 14.7, 12.0, and 10.8 in
non-diabetic white women).
DISCUSSION
In this largest to-date, cross-sectional study of black and white women from similar
geographic and socioeconomic situations, we observed that blacks have lower adiponectin
levels than whites even after adjustment for BMI. Our results expand upon previous studies
that have also found lower levels of adiponectin in blacks but were limited either by small
numbers of black participants (11–14) or limited age ranges (15–17), indicating that racial
differences in adiponectin exist across the adult age spectrum.
Adiponectin has consistently been found to be negatively correlated with obesity in white
and Asian populations (18–20). Despite racial differences in the prevalence of obesity and
risk for obesity-related disease, few large studies have examined adiponectin in relation to
obesity in blacks. As did our study, several small studies (12,14,21) as well as the
Atherosclerosis Risk in Communities Study (15) found that adiponectin decreased over
categories of BMI in blacks and that adjusted adiponectin values were lower for black
women compared to white women in each BMI category. Our analysis included larger
numbers of women with higher values of BMI than in previous studies, and we showed for
the first time that the form of the BMI-adiponectin association may differ by race with white
women showing a consistent decline in adiponectin over all levels of BMI while among
blacks, adiponectin was lower among overweight and obese women compared to healthy
weight women but there was little trend with increasing severity of obesity.
Our first-ever extensive examination of potential correlates of adiponectin found few factors
that were strongly associated with adiponectin. Adiponectin levels rose with advancing age,
consistent with earlier studies (18,22). The direction of this association has previously been
noted to be paradoxical; abdominal fat, which is inversely associated with adiponectin,
increases with age indicating that adiponectin levels should decrease with age. One potential
explanation for this seeming contradiction is that estrogen, thought to inhibit adiponectin,
decreases with age allowing adiponectin to rise (18). We also observed a strong positive
association between HDL-cholesterol and adiponectin, as have others (18,22).
Mechanistically, it is hypothesized that decreased adiponectin levels may affect hepatic
insulin resistance leading to increased hepatic lipase activity and decreased HDL levels
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(18,22). While the cross-sectional nature of our data did not allow us to examine the
temporality of the HDL-adiponectin relationship, our data demonstrate that this strong
association holds across race and age groups.
Low adiponectin levels have been inversely linked to hypertension (23–25) including in one
study of blacks (25), a finding we also observed in both race groups. A few prior studies
have found this association only among participants with insulin resistance, but at least some
evidence indicates that low adiponectin levels may affect the development of hypertension
at an early stage, without involvement of insulin resistance (24).
Based on previous examination in the literature as well as plausible roles in the physiologic
pathways through which adiponectin is believed to act, we selected additional medical
conditions for inclusion in this study, but they were ultimately not found to be important
correlates of adiponectin in our final multivariate model. We found that adiponectin levels
were only slightly lower among diabetics, and after adjustment for BMI and age, diabetes
and adiponectin were not significant associated. This was somewhat unexpected since
adiponectin and diabetes incidence have previously been shown to be inversely linked (10).
One explanation may be that many SCCS women with prevalent diabetes were receiving
treatment for their diabetes (among diabetics in this study, 75% of white women and 87% of
black women reported taking medication for their diabetes), thus reducing effects of
hyperinsulinemia on adiponectin levels. We also observed slightly lower adiponectin levels
among women reporting depression, a finding consistent with the literature to date that has
demonstrated lower adiponectin among patients with major depressive disorder and anxiety
scores (26); however, in our study, this difference was non-significant after inclusion in the
final multivariate model.
Neither physical activity nor dietary factors were predictive of adiponectin levels despite
their known roles as major components of energy balance. In contrast, a prior study found
that physical activity was associated with increased adiponectin levels, with moderate/high
intensity activity showing stronger effects than low intensity activity (27). It is possible that
the activity levels in our population were too low overall to detect effects on adiponectin
levels; in fact, less than 20% of the women in either race group in this study met the
recommended guidelines for physical activity (28). Little research has been conducted
regarding associations between dietary factors and adiponectin. One study found no
association between total calories or macronutrient intake and adiponectin (29) while fiber
was found to be positively associated with adiponectin among diabetics (30,31). It seems
likely that there are many intermediaries in the pathways linking diet and physical activity to
adiponectin, making the detection of associations difficult in our cross-sectional dataset.
Additionally, it is possible that once age, BMI, and HDL-cholesterol were included in
models for adiponectin, minimal additional predictive value was added by factors such as
diabetes, diet, and physical activity which are reasonably expected to be predictive of
adiponectin but are also strongly associated with age, BMI, and HDL-cholesterol. While
standard in large epidemiologic studies, the physical activity and dietary intakes obtained via
questionnaire rather than objective measures may also have limited the detection of
associations with adiponectin.
This study is potentially limited by our measurement of adiponectin. The high-molecular
weight (HMW) form of adiponectin has been suggested to be the more biologically active
(32) and thus, we may have been unable to detect certain associations because we (like most
other large, population-based studies) did not specifically measure HMW adiponectin.
Additionally, adiponectin was measured only at a single point in time. Studies in white and
Chinese individuals found that adiponectin levels measured one year apart were highly
correlated, indicating that a single measurement of adiponectin is likely sufficient for large
Cohen et al. Page 6













epidemiologic studies (33,34). Another possible limitation of our adiponectin measurement
is that it was not conducted exclusively in fasting samples; however, analyses limited to
samples provided more than 8 hours since the last meal did not show any appreciable
differences from those using the entire population.
The use of self-reported height and weight measures is also a potential limitation. A recent
review indicates that among women, height tends to be over-reported and weight under-
reported (35). However, data from the 1999–2004 National Health and Examination Survey
show that despite errors in self-report, BMI categories based on self-reported values still
generally demonstrate good agreement with BMI categories from measured values (36).
These data also showed that under-reporting was more common in whites and among well-
educated women (36) which suggests that the BMI values calculated from self-report in the
SCCS may be less vulnerable to bias than in other studies of more educated, white
participants. Furthermore, in the SCCS, BMI values calculated from self-reported height and
weight were very highly correlated with BMI values calculated from medical record data
overall (Pearson correlation coefficient > 0.95) as well as across strata of BMI, race,
education, and income, indicating that the self-reported values are generally of good quality.
An additional study limitation is the absence of a measurement of central obesity as it has
been shown that the amount of centrally-deposited adipose tissue differs between black and
white women at the same level of BMI (37) and further, that there are differences in the
proportion of the various isoforms of adiponectin in relation to measures of central obesity
across race groups (38).
A major strength of this study is the utilization of the SCCS resource. While the women
included in this study do not reflect the distribution of all women in the US due to the
recruitment of SCCS participants via CHCs, the SCCS participants are generally reflective
of the 14 million users of CHCs in the US who represent a largely understudied group of
individuals at high risk for many diseases. More importantly, within-population comparisons
such as those presented here, are valid regardless of generalizability. Indeed, by design, the
black and white participants in this study arose from similar geographic and SES
backgrounds facilitating the examination of racial differences by minimizing the potential
role of SES-driven confounding, a limitation that clouds the interpretation of results from
many previous studies. Our study also overcomes limitations from previous studies which
were hampered by small numbers of black participants, narrow age ranges, and few
participants with BMI greater than 35.
Analysis of this large population of highly comparable black and white women shows that
adiponectin levels are lower in blacks than in whites and that adiponectin is inversely
associated with obesity but the shape of the BMI-adiponectin association differs by race.
Additionally, we demonstrated that age, HDL-cholesterol, and hypertension are strong
correlates of adiponectin in both race groups. Future work within the SCCS and other
studies with diverse populations will be guided by these findings as the mechanistic role
played by adiponectin in the development of disease is examined. Further, efforts to develop
treatments that can alter adiponectin levels or even therapeutic applications of adiponectin
itself for diseases such as cardiovascular disease, cancer, and diabetes may be guided by the
racial differences in adiponectin levels and its correlates observed in this study.
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body mass index categories in 996 black and 996 white women in the Southern Community
Cohort Study, 2002–2006. Geometric means are adjusted for age, sample selection, and
HDL-cholesterol.
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